{
  "id": 18049703,
  "title": "Three reasons to bet now on European pharmaceuticals",
  "url": "https://urgent.news/2026/11/04/tres-razones-para-apostar-ahora-por-las-farmaceuticas-europeas",
  "topic": "business",
  "section": "Business",
  "published": "2026-11-04T00:03:44.000Z",
  "source": {
    "name": "Expansion ES",
    "slug": "expansion-es",
    "url": "https://www.expansion.com/mercados/2026/11/04/tres-razones-apostar-farmaceuticas-europeas.html"
  },
  "original_language": "es",
  "account": "1. The French pharmaceutical sector has gained attention as a defensive alternative amid market instability, as its exposure to the US market (over 40% of its sales) and the potential impact of a Democratic Party victory in the midterm elections on health policy are seen as positive factors.\n\n2. Société Générale analysts have identified three reasons for maintaining a strong position in the pharmaceutical sector: its exposure to the US market, its potential as an alternative to investments in artificial intelligence (AI), and its diversification benefits compared to other macroeconomic risks.",
  "summary": "The outbreaks of instability in the markets have intensified the search for safe havens. The pharmaceutical sector presents itself as a natural defensive alternative without leaving equities. Read",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}